Cargando…
Myasthenia gravis following human papillomavirus vaccination: a case report
BACKGROUND: Myasthenia gravis (MG), an autoimmune neuromuscular disorder, occurs owing to autoantibodies against acetylcholine receptors. MG symptoms can be triggered by various vaccines. Many studies have evaluated the safety and adverse events of the human papillomavirus (HPV) vaccine. Here, we pr...
Autores principales: | Chung, Ji Yeon, Lee, Seung Jae, Shin, Byoung-Soo, Kang, Hyun Goo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309058/ https://www.ncbi.nlm.nih.gov/pubmed/30593270 http://dx.doi.org/10.1186/s12883-018-1233-y |
Ejemplares similares
-
Myasthenia gravis after the third dose of human papillomavirus 9-valent vaccine: A case report
por: Ding, Yuan, et al.
Publicado: (2023) -
The Impacts of Influenza Infection and Vaccination on Exacerbation of Myasthenia Gravis
por: Seok, Hung Youl, et al.
Publicado: (2017) -
Early-Onset Myasthenia Gravis Following COVID-19 Vaccination
por: Lee, Myung Ah, et al.
Publicado: (2022) -
The Epidemiology of Myasthenia Gravis in Korea
por: Lee, Hyung Seok, et al.
Publicado: (2016) -
Initial Repetitive Nerve Stimulation Test Predicts Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis
por: Kim, Ki Hoon, et al.
Publicado: (2021)